PHP
AZTA icon

Parkman Healthcare Partners’s Azenta AZTA Stock Holding History

Parkman Healthcare Partners’s Portfolio AZTA Stock Details AZTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-36,554
Closed -$3.77M – 82
2021
Q4 		$3.77M Sell
36,554
-3,446
-9% -$374K 0.83% 38
2021
Q3 		$4.09M Buy
+40,000
New +$3.58M 1.04% 32

Other funds holding AZTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Parkman Healthcare Partners's AZTA Position: Q1 2022 in Review

Parkman Healthcare Partners sold out of Azenta (AZTA) in Q1 2022, closing a stake of 36,554 shares — an estimated $3.77M sold.

Parkman Healthcare Partners first reported a position in AZTA in Q3 2021 and held it in 2 quarters. The position peaked at $4.09M in Q3 2021. 383 funds tracked by Wall St. Rank hold AZTA as of Q1 2022.

  • Parkman Healthcare Partners reported no remaining Azenta position as of Q1 2022 after selling out during the quarter.
  • Parkman Healthcare Partners sold 36,554 Azenta shares in Q1 2022, an estimated $3.77M.
  • Parkman Healthcare Partners first reported a position in Azenta in Q3 2021 and held it in 2 quarters.
  • Parkman Healthcare Partners's Azenta position peaked at $4.09M in Q3 2021.
  • 383 funds tracked by Wall St. Rank held Azenta as of Q1 2022.

Based on Parkman Healthcare Partners's 13F filing for Q1 2022, filed 13 May 2022.